Although somatic mutations in BRCA1 are rare, reduced or absent protein expression has been observed in up to 90% of sporadic ovarian tumors indicating that epigenetic factors, mainly promoter hypermethylation, are also involved in its regulation [16]–[18]. This evidence concerns the gene BRCA1 and ovarian neoplasm.